ACTB and chronic kidney disease: Shen et al. demonstrated a statistically significant increase in NQO1 expression (p < 0.01 for NQO1/Actin beta (ACTB); p < 0.001 for NQO1/60S ribosomal protein L41 (RPL41) and p < 0.001 for NQO1/TATA-box binding protein (TBP)) in monocytes isolated from patients with non-haemodialysis-dependent CKD.